Express

NASDAQ-listed company Silo Pharma announces first purchase of RSC tokens

Summary: According to official sources, diversified biopharmaceutical and crypto financial management company Silo Pharma, Inc. (NASDAQ: SILO) announced today its first purchase of ResearchCoin (RSC) as a key step in expanding its digital asset financial strategy, aiming to capture long-term value from emerging multi-chain opportunities. RSC is the native token of the decentralized research collaboration platform ...

According to official sources, diversified biopharmaceutical and crypto financial management company Silo Pharma, Inc. (NASDAQ: SILO) announced today its first purchase of ResearchCoin (RSC) as a key step in expanding its digital asset financial strategy, aiming to capture long-term value from emerging multi-chain opportunities. RSC is the native token of the decentralized research collaboration platform ResearchHub, co-founded by Coinbase CEO Brian Armstrong in 2019. Silo Pharma CEO Eric Weisblum stated: 'By acquiring RSC, we are not only participating in the growing decentralized science (DeSci) movement, but also diversifying assets and potentially adding value for shareholders. Our investment in ResearchCoin demonstrates our focus on modernizing research collaboration and supporting blockchain-driven innovation as a cornerstone of biomedical discovery.'

Last Update:

Tags:
Link: NASDAQ-listed company Silo Pharma announces first purchase of RSC tokens   [Copy]
  • The Road to 2026: Where Is the Web3 Ecosystem Heading Next? December 7, 2025
  • Vishwa Advances Agentic Infrastructure Research Through Contribution to Emerging Framew... November 22, 2025
  • BitMart US Launches Operations with 49-State Licensing and Zero-Fee Program November 17, 2025
  • Global Financial Giants Enter Stablecoin Arena in Pivotal Shift October 30, 2025
  • CRYPTO'S NEW PLAY: 24/7 STOCK TRADING October 29, 2025
  • You need to login to comment.